American Research & Management Co. bought a new stake in shares of Danaher Co. (NYSE:DHR) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 500 shares of the conglomerate’s stock, valued at approximately $66,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of DHR. Norges Bank bought a new position in Danaher during the 4th quarter valued at about $747,082,000. Oregon Public Employees Retirement Fund lifted its stake in Danaher by 10,085.3% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 6,795,666 shares during the period. Findlay Park Partners LLP lifted its stake in Danaher by 25.0% during the 4th quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock valued at $473,836,000 after acquiring an additional 920,000 shares during the period. 1832 Asset Management L.P. lifted its stake in shares of Danaher by 74.3% in the 4th quarter. 1832 Asset Management L.P. now owns 2,129,142 shares of the conglomerate’s stock worth $219,310,000 after purchasing an additional 907,593 shares during the period. Finally, AQR Capital Management LLC lifted its stake in shares of Danaher by 48.2% in the 3rd quarter. AQR Capital Management LLC now owns 2,682,662 shares of the conglomerate’s stock worth $291,498,000 after purchasing an additional 872,626 shares during the period. Institutional investors and hedge funds own 77.59% of the company’s stock.
Several equities analysts have recently weighed in on DHR shares. Deutsche Bank increased their price objective on shares of Danaher to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Royal Bank of Canada reiterated a “hold” rating and issued a $102.00 price objective on shares of Danaher in a research note on Wednesday, December 19th. Needham & Company LLC started coverage on shares of Danaher in a research note on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 price objective on the stock. Jefferies Financial Group increased their price objective on shares of Danaher to $140.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Finally, UBS Group increased their price objective on shares of Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $125.46.
Shares of NYSE:DHR opened at $128.18 on Wednesday. Danaher Co. has a twelve month low of $94.59 and a twelve month high of $134.50. The company has a current ratio of 1.47, a quick ratio of 1.07 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $93.40 billion, a PE ratio of 28.36, a price-to-earnings-growth ratio of 2.41 and a beta of 1.04.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $5.40 billion during the quarter, compared to analyst estimates of $5.33 billion. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.19 EPS. As a group, analysts expect that Danaher Co. will post 4.79 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.53%. This is a positive change from Danaher’s previous quarterly dividend of $0.16. The ex-dividend date of this dividend is Thursday, March 28th. Danaher’s dividend payout ratio is currently 15.04%.
COPYRIGHT VIOLATION NOTICE: This article was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.com-unik.info/2019/04/17/american-research-management-co-buys-shares-of-500-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.